BioSpace News Archive

While the focus has been on M&A activity, Venture Capital firms have been investing billions in Biotech companies in 2018.

Sporting-related cervical fractures increased by 35 percent from 2000 to 2015, mainly due to an increase in cycling-related injuries, according to research study.

A new study presented at the 2018 Annual Meeting of the American Academy of Orthopaedic Surgeonss (AAOS) looked at primary anterior cruciate ligament (ACL) reconstructions among high-level athletes, and found that a return to play checklist decreased the incidence of injury to the knee following ACL reconstruction.

New research from two studies demonstrated the substantial psychosocial impact parents can have on their children’s sports experience, as 54.7 percent of parents encouraged their children to specialize in a single sport.

Epitinib is a potent and highly selective oral EGFR inhibitor that has demonstrated penetration of the blood-brain barrier and encouraging efficacy in clinical studies in other indications.

The new discovery group will enhance current capabilities in translational research

Dr. Limburg is a gastroenterologist and a professor of medicine at Mayo Clinic. He is also a co-leader of the Cancer Prevention and Control program within Mayo Clinic Cancer Center.

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.

Continued progress and execution according to plan on multiple clinical trials for the Company’s lead oncology program, BL-8040.

Mr. Whitcomb joins HepQuant with 20+ years of experience in the life science and medical diagnostics industry.